About this trial
This study was planned to investigate the efficacy of different treatment methods that can be used in the treatment of hemorrhagic tears that may occur in the postpartum period. The volunteers who will participate in the study will be evaluated during the hospitalization period after delivery and at the end of the puerperium 6 weeks after delivery, in accordance with routine postpartum control examinations. In the treatment of postpartum hemorrhagic tears, the treatment options such as suturing the tears to stop bleeding or applying tampons with bleeding stopping agent (chitosan) and compression effect to the torn area will be determined completely randomly.
Eligibility criteria
Qualifiers
Women who delivered at the Department of Obstetrics and Gynecology of Istanbul Training and Research Hospital between March 2025 and March 2027.
Age between 18 and 48 years.
Presence of a bleeding postpartum obstetric laceration (first- or second-degree) without an anatomical defect requiring surgical repair.
Absence of additional conditions that may affect the amount of postpartum bleeding, such as uterine atony or retained placental tissue.
Disqualifiers
Age younger than 18 years or older than 48 years.
Absence of a bleeding postpartum first- or second-degree obstetric laceration meeting the study criteria.
Presence of an obstetric laceration with an anatomical defect requiring surgical repair.
Presence of additional causes or conditions that may affect postpartum blood loss, such as uterine atony or retained placental tissue.
Trial design
Treatments tested in this trial
- Chitosan-covered-gauze application
- Suturation